Author:
Chen Ying-Jie,Liu Yu-Xi,Wu Jia-Ying,Li Chun-Yu,Tang Min-Min,Bai Lu,Fu Xiu-Qiong,Li Jun-Kui,Chou Ji-Yao,Yin Cheng-Le,Wang Ya-Ping,Bai Jing-Xuan,Wu Ying,Wang Xiao-Qi,Yu Zhi-Ling
Abstract
AbstractFibroblast-like synoviocytes (FLS) play a pathogenic role in rheumatoid arthritis (RA). STAT3 signaling is activated in FLS of RA patients (RA-FLS), which in turn causes RA-FLS hyperproliferation. RL is a traditional remedy for treating inflammatory diseases in China. It comprises Rosae Multiflorae Fructus and Lonicerae Japonicae Flos. A standardized ethanolic extract of RL (RLE) has been shown to exert anti-arthritic effects in collagen-induced arthritis (CIA) rats. Some constituents of RLE were reported to inhibit JAK2/STAT3 signaling in rat FLS. Here, we determined whether RLE inhibits FLS hyperproliferation, and explored the involvement of STAT3 signaling in this inhibition. In joints of CIA rats, RLE increased apoptotic FLS. In IL-6/sIL-6R-stimulated RA-FLS, RLE reduced cell viability and evoked cell apoptosis. In synovial tissues of CIA rats, RLE lowered the protein level of phospho-STAT3. In IL-6/sIL-6R-stimulated RA-FLS, RLE inhibited activation/phosphorylation of STAT3 and JAK2, decreased the nuclear localization of STAT3, and downregulated protein levels of Bcl-2 and Mcl-1. Over-activation of STAT3 diminished RLE’s anti-proliferative effects in IL-6/sIL-6R-stimulated RA-FLS. In summary, RLE inhibits hyperproliferation of FLS in rat and cell models, and suppression of STAT3 signaling contributes to the underlying mechanisms. This study provides further pharmacological groundwork for developing RLE as a modern anti-arthritic drug.
Funder
Guangdong Provincial Department of Science and Technology
National Natural Science Foundation of China
Shenzhen Science and Technology Innovation Commission
Research Grants Council of Hong Kong
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Wasserman, A. Rheumatoid arthritis: Common questions about diagnosis and management. Am. Fam. Physician 97, 455–462 (2018).
2. Mor, A., Abramson, S. B. & Pillinger, M. H. The fibroblast-like synovial cell in rheumatoid arthritis: A key player in inflammation and joint destruction. Clin. Immunol. 115, 118–128 (2005).
3. Krause, A., Scaletta, N., Ji, J.-D. & Ivashkiv, L. B. Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J. Immunol. 169, 6610–6616 (2002).
4. Houssiau, F. A., Devogelaer, J. P., Van Damme, J., De Deuxchaisnes, C. N. & Van Snick, J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784–788 (1988).
5. Hashizume, M. & Mihara, M. The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis. Arthritis 20, 11 (2011).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献